United States · FDA National Drug Code directory

Lorazepam

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1694_055d96f0-cf01-4766-8627-ee66cd8a291d
Product NDC
71335-1694
Form
TABLET
Composition / generic term
Lorazepam
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20170324
Source listing expiry
20271231

Source-listed ingredients

  • LORAZEPAM — 1 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 TABLET in 1 BOTTLE (71335-1694-0) · 71335-1694-0
  • 30 TABLET in 1 BOTTLE (71335-1694-1) · 71335-1694-1
  • 120 TABLET in 1 BOTTLE (71335-1694-2) · 71335-1694-2
  • 15 TABLET in 1 BOTTLE (71335-1694-3) · 71335-1694-3
  • 14 TABLET in 1 BOTTLE (71335-1694-4) · 71335-1694-4
  • 90 TABLET in 1 BOTTLE (71335-1694-5) · 71335-1694-5
  • 50 TABLET in 1 BOTTLE (71335-1694-6) · 71335-1694-6
  • 60 TABLET in 1 BOTTLE (71335-1694-7) · 71335-1694-7
  • 45 TABLET in 1 BOTTLE (71335-1694-8) · 71335-1694-8
  • 100 TABLET in 1 BOTTLE (71335-1694-9) · 71335-1694-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →